Form 4: Life360 Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Life360 Director John Philip Coghlan sold a total of 3,125 common shares on October 1, 2025, through a pre-arranged 10b5-1 trading plan.
Summary
- John Philip Coghlan, a Director of Life360, Inc., reported the sale of 3,125 shares of common stock on October 1, 2025.
- The sales were executed pursuant to a Rule 10b5-1 trading plan adopted by Coghlan on December 6, 2024.
- A total of 2,701 shares were sold at a weighted average price of $105.28 per share, with individual transaction prices ranging from $104.84 to $105.73.
- An additional 424 shares were sold at a weighted average price of $105.99 per share, with individual transaction prices ranging from $105.84 to $106.05.
- Following these transactions, Coghlan directly holds 3,344 shares, which include 2,508 restricted stock units.
- Indirect beneficial ownership includes 6,250 shares held by the John Coghlan Living Trust and 67,604 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust.
Sentiment
Score: 5
Explanation: The sale was executed under a pre-arranged 10b5-1 trading plan, which mitigates concerns about opportunistic insider selling, making the sentiment neutral.
Positives
- The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, adopted on December 6, 2024, indicating a structured and pre-determined sale not based on immediate material nonpublic information.
Negatives
- A director's sale of common stock reduces insider ownership, which can sometimes be perceived as a lack of confidence in the company's future prospects, even when pre-planned.
Risks
- Potential for negative market sentiment if investors interpret the director's sale as a signal of reduced confidence, despite the transparency provided by the 10b5-1 plan.
Future Outlook
No forward-looking statements or guidance were provided in this filing, as it pertains solely to insider transaction reporting.
Industry Context
This filing is a standard insider transaction report and does not contain information directly related to broader industry trends or competitors.
Related Party Transactions
- Indirect beneficial ownership of shares is held by the John Coghlan Living Trust and The John Philip Coghlan 2025 Grantor Retained Annuity Trust, both related parties to the reporting person.
Stakeholder Impact
- Minor potential impact on shareholder sentiment due to director selling, though mitigated by the transparency of the 10b5-1 plan.
Key Dates
| Date | Description |
|---|---|
| 12/06/2024 | Date Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 10/01/2025 | Date of the reported stock transactions (sales). |
| 10/03/2025 | Date the Form 4 was signed. |
Recommendation
holdThe director's sale of shares, while executed under a pre-arranged 10b5-1 plan, represents a reduction in insider ownership. This is a neutral to slightly negative signal, but not strong enough to warrant a 'sell' recommendation without further information on the company's fundamentals or other market factors. Therefore, a 'hold' recommendation is appropriate.
Keywords
Life360, LIF, Form 4, insider trading, stock sale, director, 10b5-1 plan, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.